Incyte | INCY - 销售和管理费用

金融业

USD 113.27

USD 7.87B

现金及等价物

USD 3.98B

USD 104.96M

USD 6.03B

USD 1.31B

USD 38.27M

USD 700.4M

USD 778.57M

2.62K

EPS每股收益

USD 3.09

股本和储备

USD 6.34B

USD 1.57B

债务利息支出

USD 582K

USD 38.12M

USD 28.42M

USD 25.58B

USD 585.61M

USD 973.64M

USD 700.4M

普通股股本

USD 200.98M

14.45

USD 751.51M

USD 1.67B

销售和管理费用

USD 351.74M

USD 112.54M

贸易债权人

USD 1.39B

应收帐款人

USD 1.13B

	销售和管理费用	更改		日
Acadia Pharmaceuticals	USD 148.57M		12.22M	2026-06
Agenus	USD 6.21M		4.34M	2026-03
Agios Pharmaceuticals	USD 38.46M		4.51M	2026-03
Alnylam Pharmaceuticals	USD 347.92M		65.41M	2026-06
Amgen	USD 1.72B		134M	2026-06
BioCryst Pharmaceuticals	USD 63.98M		31.8M	2026-06
Biogen	USD 709.7M		155.4M	2026-06
BioMarin Pharmaceutical	USD 395.55M		137.27M	2026-06
Bristol-Myers Squibb	USD 1.83B		209M	2026-06
Eli Lilly	USD 3.43B		496M	2026-06
Exelixis	USD 147.63M		8.03M	2026-06
Gilead Sciences	USD 1.52B		70M	2026-06
Incyte	USD 351.73M		23.64M	2026-06
Ionis Pharmaceuticals	USD 130.07M		20.92M	2026-06
MacroGenics	USD 9.71M		1.77M	2026-03
Merck	USD 2.89B		219M	2026-06
Moderna	USD 216M		43M	2026-06
Nektar Therapeutics	USD 11.87M		1.7M	2026-03
Neurocrine Biosciences	USD 383.1M		64.6M	2026-06
Novartis	USD 3.24B		101M	2026-06
Novartis	USD 3.14B		296M	2026-03
Pfizer	USD 3.41B		496M	2026-06
PTC Therapeutics	USD 73.89M		13.31M	2026-03
Puma Biotechnology	USD 16.82M		8.15M	2024-09
Regeneron Pharmaceuticals	USD 662.1M		14.4M	2026-06
Sarepta Therapeutics	USD 107.6M		53.57M	2026-06
Ultragenyx Pharmaceutical	USD 88M		1000K	2026-03
Vertex Pharmaceuticals	USD 582.2M		88.5M	2026-06